1West China School of Pharmacy, Sichuan University, Chengdu, CHINA
2Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, CHINA
3School of Pharmacy, Peking University, Haidian, CHINA
4Yihong College of Business, Shenyang Pharmaceutical University, Liaoning, CHINA
Corresponding author.
Author Notes
Copyright and License information
ABSTRACT
Background
To evaluate the value of pharmaceutical care, and sort out the existing problems in the current researches.
Materials and Methods
We established the research strategy and searched seven databases. Two reviewers independently screened the studies, extracted data, conducted the statistical analysis and assessed the quality of full economic evaluations. The pharmaceutical care was divided into 9 types based on the relevant standards of Chinese Hospital Association.
Results
332 studies were included. The methods were mainly cohort studies (n=187, 56.32%), and followed by randomized controlled trials (n=124, 37.35%). Only 23 studies were conducted as full economic evaluations. The Quality of Health Economic Studies score was 61.22±12.80. The most commonly used effect indicators included length of hospital stay (n=166, 50%), prescription rationality rate (n=166, 50%), incidence of adverse reactions (n=117, 35.24%) and course of medication (n=107, 32.23%). For economic indicators, the cost of medication (n=269, 81.02%) and hospitalization (n=113, 34.04%) were the most frequently used indicator. The research results showed that pharmaceutical care could improve the therapeutic effect. 91.45% and 81.42% of the studies revealed that pharmaceutical care could reduce the cost of medication and hospitalization.
Conclusion
Pharmaceutical care can improve the therapeutic effect and save the cost. However, the methodology of pharmaceutical care effect and economic evaluation needs to be further improved.